Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.5Revenue $M29.1Net Margin (%)0Z-Score5.4
Enterprise Value $M48.8EPS $-0.7Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book3.010-y EBITDA Growth Rate %0Quick Ratio11.4Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio11.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-37.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-48.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M34.1ROI % (ttm)-107.2Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BLRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BLRX :

    Quarterly/Annual Reports about BLRX:

      News about BLRX:

      Articles On GuruFocus.com
      No related article found.

      More From Our Partners
      Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 24 2015 - ZACKS

      More From Other Websites
      Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 24 2015
      BioLineRx to Present at 2015 BIO CEO & Investor Conference in New York on February 10 Feb 21 2015
      Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 17 2015
      Zacks Rank #1 Additions for Wednesday - Tale of the Tape Feb 11 2015
      Zacks Rank #1 Additions for Tuesday - Tale of the Tape Feb 03 2015
      BioLineRx to Present at 2015 BIO CEO & Investor Conference in New York on February 10 Feb 03 2015
      ARIAD's Iclusig Endorsed by EC for All Approved Indications - Analyst Blog Jan 21 2015
      VBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors Jan 20 2015
      VBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors Jan 20 2015
      Zacks Rank #1 Additions for Monday - Tale of the Tape Jan 19 2015
      BioLineRx Announces Completion of Enrollment in CE Mark Registration Trial of BCM (BL-1040), a Novel... Jan 14 2015
      BioLineRx Announces Completion of Enrollment in CE Mark Registration Trial of BCM (BL-1040), a Novel... Jan 14 2015
      BioLineRx Completes Dose Escalation Stage of Phase 1 Trial for Novel Stem Cell Mobilization... Jan 07 2015
      BioLineRx Completes Dose Escalation Stage of Phase 1 Trial for Novel Stem Cell Mobilization... Jan 06 2015
      BioLineRx to Present at Biotech Showcase 2015 Conference in San Francisco Jan 06 2015
      BioLineRx to Present at Biotech Showcase 2015 Conference in San Francisco Jan 06 2015
      BioLineRx Out-Licenses Novel Skin Lesion Treatment to Omega Pharma Dec 23 2014
      BioLineRx Out-Licenses Novel Skin Lesion Treatment to Omega Pharma Dec 23 2014
      BioLineRx and Major Global Pharmaceutical Company Form Strategic Collaboration for Screening and... Dec 16 2014
      BioLineRx and Major Global Pharmaceutical Company Form Strategic Collaboration for Screening and... Dec 16 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK